ArticleBriefings in bioinformatics2026
DFRL-Mol: a dual-stage framework of reinforcement learning for multi-scenario molecule optimization.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a critical step in drug discovery, molecule optimization aims to improve specific properties of lead compounds. Inspired by isosteres (i.e. molecular substructures with similar reactive electron shells), existing AI-based methods have been proposed for molecule optimization. However, they often rely on available matched molecular pairs (MMPs), thus facing two essential challenges. First, the limited diversity of available MMPs leads to biased training and a lack of novelty in the optimized molecules, in both single-objective (SO) and multi-objective (MO) optimization. Second, the low number of available MMPs leads to limited generalization in MO optimization. To overcome the limitations of MMPs, we propose DFRL-Mol, a novel dual-stage reinforcement learning framework. It consists of three main modules: the Structure-Property Analyst (SPA), the Decorator (DCR), and Curriculum-guided Dual-Stage Policy Optimization (CDSPO). SPA and DCR are two LLM-based models, which are responsible for locating the substructures to be optimized and inferring their appropriate isosteric replacement, respectively. CDSPO leverages curriculum-guided reinforcement learning to facilitate collaboration between the two models. DFRL-Mol ensures the generation of diverse molecular representations while effectively overcoming the issues of bias and data sparsity associated with MMPs. The comparisons with state-of-the-art methods demonstrate the enhanced performance of DFRL-Mol in multiple scenarios of molecule optimization, including SO optimization, substructure-constrained (SC) SO optimization, MO optimization, and MO molecule generation. More importantly, detailed analysis of experimental results demonstrates that the models' behavior is consistent with chemical intuition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.